Oruka Stock Is Now Up Nearly 700%. Here’s What a $687,000 Insider Sale Could Mean
Arjun Agarwal, Senior Vice President, Finance of Oruka Therapeutics (NASDAQ:ORKA), reported the direct sale of 9,854 shares of Common Stock for proceeds of approximately $687K across June 12 and June 15, 2026, according to the SEC Form 4 filing. Transaction summary Transaction value based on SEC Form 4 weighted average purchase price ($69.72); post-transaction value…
